Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Am Acad Child Adolesc Psychiatry ; 48(2): 166-75, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19127171

ABSTRACT

OBJECTIVE: To evaluate the effects of stimulant medication on organizational, time management, and planning (OTMP) in children with attention-deficit/hyperactivity disorder (ADHD) and ascertain whether OTMP is normalized with medication. METHOD: Participants included 19 stimulant-naïve children with ADHD (aged 8-13 years) and impaired OTMP functioning, defined as greater than 1 SD below norms on the Children's Organizational Skills Scale. A double-blind, placebo-controlled, crossover design, with 4 weeks of each condition, evaluated medication (methylphenidate-osmotic-release oral system [MPH-OROS]) effects on OTMP, based on the parent and teacher versions of the Children's Organizational Skills Scale. The parent and teacher Swanson, Nolan, and Pelham, Version IV, rating scales assessed ADHD symptoms. "Not impaired" in OTMP was defined as no longer meeting study entry criteria, and "not impaired" in ADHD symptoms was defined as having mean Swanson, Nolan, and Pelham, Version IV, scores of < or = 1.0. RESULTS: MPH-OROS significantly improved children's OTMP behaviors. These improvements were correlated with significant reductions in ADHD symptoms. However, most of the children (61%) continued to show significant OTMP impairments on MPH-OROS. CONCLUSIONS: The MPH-OROS reduced children's OTMP deficits, and these improvements were associated with improvements in ADHD symptoms. Some children remained impaired in OTMP even after effective stimulant treatment of ADHD symptoms. These youngsters may require other treatments that target OTMP deficits.


Subject(s)
Attention Deficit Disorder with Hyperactivity/drug therapy , Methylphenidate/therapeutic use , Administration, Oral , Adolescent , Attention Deficit Disorder with Hyperactivity/psychology , Central Nervous System Stimulants/administration & dosage , Central Nervous System Stimulants/therapeutic use , Child , Cross-Over Studies , Double-Blind Method , Drug Delivery Systems , Female , Humans , Male , Methylphenidate/administration & dosage , Psychiatric Status Rating Scales , Time Management/psychology , Treatment Outcome
2.
J Child Adolesc Psychopharmacol ; 17(5): 547-62, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17979577

ABSTRACT

OBJECTIVE: The aim of this study was to describe the clinical presentation of preschoolers diagnosed with moderate to severe attention-deficit/hyperactivity disorder (ADHD) recruited for the multisite Preschool ADHD Treatment Study (PATS). The diagnosis and evaluation process will also be described. METHOD: A comprehensive multidimensional, multi-informant assessment protocol was implemented including the semistructured PATS Diagnostic Interview. Parent and teacher-report measures were used to supplement information from interviews. Consensus agreement by a cross-site panel on each participant's diagnoses was required. Analyses were conducted to describe the sample and to test associations between ADHD severity and demographic and clinical variables. RESULTS: The assessment protocol identified 303 preschoolers (3-5.5 years) with moderate to severe ADHD Hyperactive/Impulsive or Combined type. The majority of participants (n = 211, 69.6%) experienced co-morbid disorders, with oppositional defiant disorder, communication disorders, and anxiety disorders being the most common. Participants with co-morbid communication disorders were found to be more anxious and depressed. ADHD severity was found to correlate with more internalizing difficulties and lower functioning. Although boys and girls had similar symptom presentations, younger children had significantly higher ADHD severity. CONCLUSIONS: Preschoolers with moderate to severe ADHD experience high co-morbidity and impairment, which have implications for both assessment and treatment.


Subject(s)
Attention Deficit Disorder with Hyperactivity/psychology , Anxiety Disorders/complications , Anxiety Disorders/psychology , Attention Deficit Disorder with Hyperactivity/diagnosis , Attention Deficit Disorder with Hyperactivity/epidemiology , Attention Deficit and Disruptive Behavior Disorders/complications , Attention Deficit and Disruptive Behavior Disorders/psychology , Central Nervous System Stimulants/therapeutic use , Child Behavior , Child, Preschool , Communication Disorders/complications , Communication Disorders/psychology , Data Interpretation, Statistical , Ethnicity , Female , Humans , Male , Methylphenidate/therapeutic use , Neuropsychological Tests , Prospective Studies , Psychiatric Status Rating Scales , Psychometrics , Research Design , Risk-Taking , Socioeconomic Factors , Wounds and Injuries/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL
...